iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Down 68.9% in February

iShares Health Innovation Active ETF (NYSEARCA:BMED) saw a significant drop in short interest in February. As of February 27th, there was short interest totaling 4,196 shares, a drop of 68.9% from the February 12th total of 13,489 shares. Based on an average daily trading volume, of 3,392 shares, the short-interest ratio is presently 1.2 days. Approximately 1.3% of the shares of the stock are short sold. Approximately 1.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 3,392 shares, the short-interest ratio is presently 1.2 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. acquired a new stake in iShares Health Innovation Active ETF (NYSEARCA:BMED) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned approximately 3.63% of iShares Health Innovation Active ETF as of its most recent filing with the SEC.

iShares Health Innovation Active ETF Stock Performance

iShares Health Innovation Active ETF stock traded down $0.02 during midday trading on Wednesday, hitting $29.58. 368 shares of the company’s stock were exchanged, compared to its average volume of 6,204. The company has a market cap of $9.47 million, a P/E ratio of 24.91 and a beta of 0.84. The stock has a 50-day moving average price of $30.86 and a two-hundred day moving average price of $29.25. iShares Health Innovation Active ETF has a 52-week low of $20.57 and a 52-week high of $32.19.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.